Enterprise Value
361.9M
Cash
124M
Avg Qtr Burn
-18.16M
Short % of Float
18.84%
Insider Ownership
17.19%
Institutional Own.
70.03%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
TSHA-102 Details Rett syndrome | Phase 1/2 Data readout | |
TSHA-102 Details Rett syndrome | Phase 1/2 Data readout | |
TSHA-120 Details Giant Axonal Neuropathy | Failed Discontinued | |
TSHA-118 Details Batten Disease | Failed Discontinued | |
TSHA-101 Details GM2 gangliosidosis | Failed Discontinued |